etoposide has been researched along with Sensitivity and Specificity in 73 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 27 (36.99) | 18.2507 |
| 2000's | 36 (49.32) | 29.6817 |
| 2010's | 9 (12.33) | 24.3611 |
| 2020's | 1 (1.37) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Cao, P; Gong, Y; Liang, B; Liu, Y; Lu, Y; Luo, C; Wang, J; Wang, Y; Xu, Y; Xue, J; Yan, T; Zhou, L; Zhou, X; Zhou, Y | 1 |
| Chen, W; Gao, S; Gong, X; Liang, Y; Liu, K; Yang, L; Zhang, F | 1 |
| Ai, W; Chen, Y; Huang, J; Li, D; Li, G; Si, L; Wu, S; Zhao, G | 1 |
| Bohndiek, SE; Booth, TC; Brindle, KM; Canuto, HC; Hobson, MP; Hu, DE; Kettunen, MI; Krishnan, AS; Larkin, TJ; McLachlan, C; Neves, AA | 1 |
| Brtnický, T; Fialová, A; Laštovička, J; Rob, L; Špíšek, R | 1 |
| Duan, L; Li, J; Qiu, H; Tian, T; Wang, D; Wang, J; Zhang, Q; Zhang, X | 1 |
| Guan, T; Lin, X; Tang, X; Wang, J; Xu, H; Zhang, Y | 1 |
| Chang, QY; Li, M; Li, XG; Li, YF; Liu, J; Song, PP; Tian, HM; Wang, XB; Wu, LY; Zhang, W; Zhao, D | 1 |
| Horváth, A; Horváth, E; Popşor, S | 1 |
| Demura, Y; Kimura, H; Morikawa, M; Okazawa, H; Tsuchida, T; Umeda, Y | 1 |
| Advani, R; Ambinder, RF; Bartlett, NL; Cheson, BD; Fisher, RI; Gascoyne, RD; Gellert, LL; Gordon, LI; Hong, F; Horning, SJ; Hsieh, WS; Kahl, BS; Kanakry, JA; Lemas, MV; Li, H; Miller, TP; Stiff, P; Tan, KL | 1 |
| Biola, A; Marzin, D; Meintières, S; Pallardy, M | 1 |
| Bartos, J; Kylarová, D; Lichnovský, V; Mad'arová, J; Procházková, J | 1 |
| Kato, Y; Mawatari, H; Nishimura, S; Sakura, N; Ueda, K | 1 |
| Berkarda, S; Cermik, TF; Doğanay, L; Karlikaya, C; Türe, M; Yüksel, M | 1 |
| Malik, M; Nitiss, JL | 1 |
| Cerman, J; Cervinka, M; Rudolf, E | 1 |
| Faubel, W; Heissler, S; Pütz, M; Pyell, U; Ragozina, NY | 1 |
| Kishida, T; Komiyama, M; Mori, T; Noguchi, M; Noguchi, Y; Ohnishi, M; Sawaguchi, K; Yabushita, H | 1 |
| Chandna, S | 1 |
| Cahn, JY; Coutet, J; Deconinck, E; Limat, S; Voillat, L; Woronoff-Lemsi, MC | 1 |
| Alexander, H; Alexander, S; Hanigan, MH; Min, J; Stegner, AL; Traynor, D; Zhang, L | 1 |
| Green, DR; Muñoz-Pinedo, C; van den Berg, A | 1 |
| Brindle, KM; Hu, DE; Kettunen, MI; Schmitz, JE | 1 |
| Akbulut, T; Boulares, H; Kandan, S; Oumouna, M; Yakovlev, A; Zoltoski, A | 1 |
| Gibson, SB; Henson, ES; Hu, X | 1 |
| Classen, J; Dieckmann, KP; Gertenbach, U; Hahn, E; Loy, V; Ruwe, M; Souchon, R; Stambolis, C | 1 |
| Libura, J; Richardson, C; Sung, PA | 1 |
| Akgun, A; Burak, Z; Cok, G; Goksel, T; Karapolat, I | 1 |
| Ala-Kopsala, M; Hartikainen, J; Jantunen, E; Kuittinen, T; Mussalo, H; Nousiainen, T; Vanninen, E; Vuolteenaho, O | 1 |
| De Braud, F; Di Meglio, G; Fazio, N; Grana, C; Lorizzo, K; Pelosi, G; Torrisi, R; Tradati, N | 1 |
| Furukawa, T; Hata, K; Hirai, I; Kawago, M; Kokawa, Y; Nakamura, R; Ohta, F; Okamura, Y; Oura, S; Tamaki, T; Tanino, H; Yoshimasu, T | 1 |
| Chang, CC; Gondo, G; Hayashi, A; Ito, S; Kanno, H; Kyuma, Y; Nishimura, S; Ono, A; Sasaki, T; Sato, H; Shimizu, N; Tanaka, M; Yamamoto, I | 1 |
| Carroll, M; Frankel, P; Ruel, C; Smith-Powell, L; Synold, TW; Twardowski, PW; VanBalgooy, J | 1 |
| Dietrich, S; Dimitrakopoulou-Strauss, A; Egerer, G; Haberkorn, U; Ho, AD; Kasper, B; Strauss, LG | 1 |
| Cabanillas, F; Cortes, JE; Kurzrock, R; Seymour, JF; Talpaz, M | 1 |
| Creutzig, U; Harbott, J; Löffler, H; Ludwig, WD; Riehm, H; Ritter, J; Schellong, G; Sperling, C; Zimmermann, M | 1 |
| Hamburger, AW; Mishra, S | 1 |
| Kim, K | 1 |
| Kimura, T; Onodera, K; Sato, T | 1 |
| Hsiung, Y; Liu, YX; Nitiss, JL | 1 |
| Banerjee, D; Bertino, JR; Danenberg, K; Danenberg, P; Hochhauser, D; Ju, JF; Lenz, HJ; Manno, DJ; Schnieders, B; Spears, CP | 1 |
| Elfenbein, GJ; Fields, KK; Janssen, WE; Moscinski, LC; Perkins, JB; Trudeau, WL | 1 |
| Copley-Merriman, C; Corral, J; Dorr, FA; King, K; McDonald, RC; Voi, M; Whiteside, R | 1 |
| Fabian, I; Kravtsov, VD | 1 |
| Frankfurt, OS; Robb, JA; Sugarbaker, EV; Villa, L | 1 |
| Cattan, AR; Douglas, EA; Levett, D; Middleton, PG; Taylor, PR | 1 |
| Aita, P; Boiocchi, M; Robieux, I; Sorio, R; Toffoli, G | 1 |
| Livingstone, A; Mairs, RJ | 1 |
| Bandoh, T; Kitamura, R; Satoh, T; Tsuda, M | 1 |
| Athanassiou, A; Dimitriades, M; Kostopoulou, M; Mylonakis, A; Papadopoulou, M; Pectasides, D; Triantafillis, D; Varthalitis, J | 1 |
| Jaehde, U; Schunack, W; Stremetzne, S | 1 |
| Kimura, H; Meng, H; Terado, T | 1 |
| Golub, EI; Haaf, T; Raderschall, E | 1 |
| Bishop, WR; Izbicka, E; Lawrence, RA; Petit, T; Von Hoff, DD; Weitman, S | 1 |
| Ehninger, G; Illmer, T; Neubauer, A; Nowak, R; Oelschlägel, U; Renner, U; Schaich, M; Subat, S; Ziegs, B | 1 |
| Cai, X; Edick, MJ; Relling, MV; Woo, MH | 1 |
| Hanai, H; Ishibashi, R; Kaneko, E; Osawa, S; Otake, T; Shirai, T; Suzuki, H; Takashima, M; Takayanagi, S | 1 |
| Felgenhauer, J; Hawkins, D; Radich, J; Thomson, B | 1 |
| Bonner, JA; Brooks, BJ; Gerstner, JB; Hillman, S; Jett, JR; Krook, JE; Levitt, R; Mailliard, JA; Maksymiuk, A; Marks, RS; Shanahan, TG; Sloan, JA; Tazelaar, HD | 1 |
| Albers, P; Bierhoff, E; deRiese, W; Hartmann, M; Kuczyk, M; Loy, V; Rebmann, U; Schulze, H; Siener, R; Weinknecht, S; Wittekind, C | 1 |
| Alaruikka, P; Franklin, CC; Kavanagh, TJ; Kinnula, V; Koistinen, P; Krejsa, CM; Mäntymaa, P; Savolainen, ER; Siitonen, T | 1 |
| Cotter, FE; Fennell, DA | 1 |
| Chen, CL; Uckun, FM | 1 |
| Goehle, S; Lamb, JR; Ludlow, C; Simon, JA | 1 |
| Andresen, P; Blaschke, G; Hempel, G; Schierenberg, MO; Schulz, H; Soetebeer, UB | 1 |
| Frostvik-Stolt, M; Liliemark, E; Zhou, R | 1 |
| Blair, IA; Boston, R; Felix, CA; Pang, S; Scavuzzo, J; Zheng, N | 1 |
| Bertino, JR; Cordon-Cardo, C; Elisseyeff, Y; Faircloth, G; Jhanwar, S; Jimeno, J; Li, WW; Takahashi, N | 1 |
| Castell, JV; Gómez-Lechón, MJ; Jover, R; O'Connor, E | 1 |
| Demperio, VL | 1 |
| Ansoborlo, S; Babin-Boilletot, A; Baruchel, A; Pacquement, H; Patte, C; Plouvier, E; Sakiroglu, C | 1 |
1 review(s) available for etoposide and Sensitivity and Specificity
| Article | Year |
|---|---|
Etoposide and illegitimate DNA double-strand break repair in the generation of MLL translocations: new insights and new questions.
Topics: Antineoplastic Agents, Phytogenic; Chromosome Breakage; Chromosomes, Human, Pair 11; DNA Damage; DNA Repair; DNA Topoisomerases, Type II; Etoposide; Histone-Lysine N-Methyltransferase; Humans; Leukemia, Myeloid, Acute; Models, Genetic; Myeloid-Lymphoid Leukemia Protein; Sensitivity and Specificity; Topoisomerase II Inhibitors | 2006 |
10 trial(s) available for etoposide and Sensitivity and Specificity
| Article | Year |
|---|---|
Imaging the early response to chemotherapy in advanced lung cancer with diffusion-weighted magnetic resonance imaging compared to fluorine-18 fluorodeoxyglucose positron emission tomography and computed tomography.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Diffusion Magnetic Resonance Imaging; Early Detection of Cancer; Etoposide; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome | 2013 |
Plasma Epstein-Barr virus DNA predicts outcome in advanced Hodgkin lymphoma: correlative analysis from a large North American cooperative group trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; DNA, Viral; Doxorubicin; Epstein-Barr Virus Infections; Etoposide; Female; Herpesvirus 4, Human; Hodgkin Disease; Humans; Male; Mechlorethamine; Middle Aged; Neoadjuvant Therapy; North America; Prednisone; Prognosis; Sensitivity and Specificity; Vinblastine; Vincristine; Young Adult | 2013 |
Thallium-201 SPECT in advanced non-small cell lung cancer: in relation with chemotherapeutic response, survival, distant metastasis and p53 status.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic; Survival Analysis; Thallium; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Tumor Suppressor Protein p53 | 2003 |
Tc-99m MIBI SPECT in prediction of prognosis in patients with small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Outcome Assessment, Health Care; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Survival Analysis; Survival Rate; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Turkey | 2006 |
Biologic markers of angiogenesis: circulating endothelial cells in patients with advanced malignancies treated on phase I protocol with metronomic chemotherapy and celecoxib.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Celecoxib; Cyclophosphamide; Endothelial Cells; Etoposide; Female; Flow Cytometry; Humans; Male; Middle Aged; Neoplasms; Neoplastic Cells, Circulating; Neovascularization, Pathologic; Pyrazoles; Sensitivity and Specificity; Stem Cells; Sulfonamides | 2008 |
Early prediction of therapy outcome in patients with high-risk soft tissue sarcoma using positron emission tomography.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Etoposide; Female; Fluorodeoxyglucose F18; Humans; Ifosfamide; Male; Middle Aged; Outcome Assessment, Health Care; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Risk Factors; Sarcoma; Sensitivity and Specificity; Treatment Outcome | 2008 |
Clinical significance of surface antigen expression in children with acute myeloid leukemia: results of study AML-BFM-87.
Topics: Acute Disease; Adolescent; Antibodies, Monoclonal; Antigens, CD; Antigens, Neoplasm; Antigens, Surface; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Child; Child, Preschool; Chromosome Aberrations; Combined Modality Therapy; Cranial Irradiation; Cytarabine; Daunorubicin; Disease-Free Survival; Etoposide; Humans; Immunophenotyping; Infant; Leukemia, Myeloid; Neoplastic Stem Cells; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Prospective Studies; Sensitivity and Specificity; Treatment Outcome | 1995 |
Economic value of gemcitabine compared to cisplatin and etoposide in non-small cell lung cancer.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Cost Savings; Deoxycytidine; Direct Service Costs; Drug Costs; Etoposide; Female; Gemcitabine; Health Services Research; Hospital Costs; Humans; Karnofsky Performance Status; Lung Neoplasms; Male; Middle Aged; Models, Economic; Monte Carlo Method; Oncology Service, Hospital; Sensitivity and Specificity; United States | 1996 |
Phase III comparison of twice-daily split-course irradiation versus once-daily irradiation for patients with limited stage small-cell lung carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Disease Progression; Dose Fractionation, Radiation; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Radiation Injuries; Sensitivity and Specificity; Survival Analysis | 1999 |
Risk factors for relapse in stage I non-seminomatous germ-cell tumors: preliminary results of the German Multicenter Trial. German Testicular Cancer Study Group.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Etoposide; Germinoma; Humans; Lymph Node Excision; Male; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Staging; Recurrence; Reproducibility of Results; Retrospective Studies; Risk Factors; Sensitivity and Specificity; Testicular Neoplasms; Tomography, X-Ray Computed | 1999 |
62 other study(ies) available for etoposide and Sensitivity and Specificity
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Acute severe radiation pneumonitis among non-small cell lung cancer (NSCLC) patients with moderate pulmonary dysfunction receiving definitive concurrent chemoradiotherapy: Impact of pre-treatment pulmonary function parameters.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Dose Fractionation, Radiation; Dose-Response Relationship, Radiation; Etoposide; Female; Humans; Logistic Models; Lung; Lung Neoplasms; Male; Middle Aged; Organoplatinum Compounds; Paclitaxel; Predictive Value of Tests; Proportional Hazards Models; Radiation Pneumonitis; Radiotherapy, Intensity-Modulated; Respiratory Function Tests; Retrospective Studies; Risk; ROC Curve; Sensitivity and Specificity; Severity of Illness Index | 2020 |
Validated UHPLC-MS/MS assay for quantitative determination of etoposide, gemcitabine, vinorelbine and their metabolites in patients with lung cancer.
Topics: Aged; Antineoplastic Agents; Chromatography, High Pressure Liquid; Cohort Studies; Deoxycytidine; Etoposide; Gemcitabine; Humans; Linear Models; Lung Neoplasms; Middle Aged; Reproducibility of Results; Sensitivity and Specificity; Tandem Mass Spectrometry; Vinblastine; Vinorelbine | 2017 |
Simultaneous LC-MS/MS bioanalysis of etoposide and paclitaxel in mouse tissues and plasma after oral administration of self-microemulsifying drug-delivery systems.
Topics: Administration, Oral; Animals; Chromatography, Liquid; Drug Delivery Systems; Drug Stability; Emulsions; Etoposide; Linear Models; Male; Mice; Paclitaxel; Reproducibility of Results; Sensitivity and Specificity; Tandem Mass Spectrometry; Tissue Distribution | 2018 |
Analysis of image heterogeneity using 2D Minkowski functionals detects tumor responses to treatment.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Etoposide; Female; Image Interpretation, Computer-Assisted; Lymphoma; Magnetic Resonance Imaging; Mice; Mice, Inbred C57BL; Neoplasm Staging; Prognosis; Reproducibility of Results; Sensitivity and Specificity; Stilbenes; Treatment Outcome | 2014 |
Clinical relevance of regulatory T cells monitoring in the peripheral blood of ovarian cancer patients.
Topics: Administration, Metronomic; Adult; Aged; Antineoplastic Agents; Blood Circulation; Carcinoma; Cyclophosphamide; Etoposide; Female; Humans; Immunophenotyping; Middle Aged; Monitoring, Immunologic; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Predictive Value of Tests; Prognosis; Prospective Studies; Sensitivity and Specificity; T-Lymphocytes, Regulatory; Treatment Outcome | 2015 |
The significance of pre-therapeutic F-18-FDG PET-CT in lymphoma-associated hemophagocytic lymphohistiocytosis when pathological evidence is unavailable.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Female; Fluorodeoxyglucose F18; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Kaplan-Meier Estimate; Lymphohistiocytosis, Hemophagocytic; Lymphoma; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prednisone; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome; Vincristine | 2016 |
Determination of teniposide in rat plasma by ultra performance liquid chromatography electrospray ionization tandem mass spectrometry after intravenous administration.
Topics: Animals; Antineoplastic Agents; Chemical Fractionation; Chromatography, High Pressure Liquid; Drug Stability; Etoposide; Female; Injections, Intravenous; Linear Models; Rats; Rats, Wistar; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Teniposide | 2009 |
[Application of ATP-tumor chemosensitivity assay in recurrent epithelial ovarian cancer].
Topics: Adenosine Triphosphate; Antineoplastic Combined Chemotherapy Protocols; CA-125 Antigen; Carcinoma, Endometrioid; Cystadenocarcinoma, Serous; Deoxycytidine; Disease-Free Survival; Doxorubicin; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Etoposide; Female; Follow-Up Studies; Gemcitabine; Humans; Luminescent Measurements; Neoplasm Recurrence, Local; Ovarian Neoplasms; Paclitaxel; Predictive Value of Tests; Retrospective Studies; Sensitivity and Specificity; Survival Rate; Topotecan | 2010 |
Mandibular ameloblastic carcinoma in a young patient.
Topics: Ameloblastoma; Biopsy; Bone Marrow; Carboplatin; Child; Etoposide; Female; Humans; Mandibular Neoplasms; Neoplasm Metastasis; Odontogenic Tumors; Pleural Effusion; Prognosis; Sensitivity and Specificity; Treatment Outcome | 2012 |
Using CTLL-2 and CTLL-2 bcl2 cells to avoid interference by apoptosis in the in vitro micronucleus test.
Topics: Animals; Annexin A5; Apoptosis; Cells, Cultured; Dexamethasone; Etoposide; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Mice; Mice, Inbred C57BL; Micronucleus Tests; Mutagens; Proto-Oncogene Proteins c-bcl-2; Sensitivity and Specificity; T-Lymphocytes, Cytotoxic | 2003 |
Comparison of the TUNEL, lamin B and annexin V methods for the detection of apoptosis by flow cytometry.
Topics: Annexin A5; Apoptosis; Dactinomycin; DNA Fragmentation; Enzyme Inhibitors; Etoposide; Flow Cytometry; Fluorescent Antibody Technique, Indirect; HL-60 Cells; Humans; In Situ Nick-End Labeling; Kinetin; Lamin Type B; Purines; Sensitivity and Specificity | 2002 |
Determination of etoposide serum concentrations in small pediatric samples by an improved method of reversed-phase high-performance liquid chromatography.
Topics: Antineoplastic Agents, Phytogenic; Calibration; Chromatography, High Pressure Liquid; Etoposide; Humans; Sensitivity and Specificity | 2003 |
DNA repair functions that control sensitivity to topoisomerase-targeting drugs.
Topics: Camptothecin; Cell Cycle; DNA Damage; DNA Repair; Dose-Response Relationship, Radiation; Enzyme Inhibitors; Etoposide; Genotype; Mutation; Plasmids; Recombination, Genetic; Schizosaccharomyces; Sensitivity and Specificity; Temperature; Time Factors; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors; X-Rays | 2004 |
Apoptosis in Hep2 cells treated with etoposide and colchicine.
Topics: Apoptosis; Cell Division; Colchicine; DNA Fragmentation; Dose-Response Relationship, Drug; Drug Therapy, Combination; Etoposide; Humans; Microscopy, Video; Reference Values; Sensitivity and Specificity; Tumor Cells, Cultured | 2004 |
Quantification of etoposide and etoposide phosphate in human plasma by micellar electrokinetic chromatography and near-field thermal lens detection.
Topics: Chromatography, Micellar Electrokinetic Capillary; Etoposide; Humans; Lenses; Molecular Structure; Organophosphorus Compounds; Sensitivity and Specificity; Surface Properties; Temperature | 2004 |
Usefulness of collagen gel droplet embedded culture drug sensitivity testing in ovarian cancer.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Camptothecin; Cell Culture Techniques; Cell Line, Tumor; Chemotherapy, Adjuvant; Cisplatin; Clinical Laboratory Techniques; Collagen; Disease Progression; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Female; Gels; Humans; Irinotecan; Middle Aged; Ovarian Neoplasms; Paclitaxel; Pharmaceutical Preparations; Recurrence; Remission Induction; Sensitivity and Specificity; Time Factors; Treatment Outcome | 2004 |
Single-cell gel electrophoresis assay monitors precise kinetics of DNA fragmentation induced during programmed cell death.
Topics: Animals; Apoptosis; Cell Line, Tumor; CHO Cells; Comet Assay; Cricetinae; DNA Fragmentation; Etoposide; Humans; Hydrogen-Ion Concentration; Image Processing, Computer-Assisted; Kinetics; Nucleic Acid Synthesis Inhibitors; Reproducibility of Results; Salts; Sensitivity and Specificity; Time Factors | 2004 |
[Economic impact of outpatient chemotherapy in multiple myeloma].
Topics: Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Etoposide; Female; France; Hospital Costs; Hospitalization; Humans; Male; Middle Aged; Multiple Myeloma; Retrospective Studies; Sensitivity and Specificity | 2004 |
Sphingosine kinase regulates the sensitivity of Dictyostelium discoideum cells to the anticancer drug cisplatin.
Topics: Adenosine Triphosphate; Amino Acid Sequence; Animals; Antineoplastic Agents; Blotting, Western; Cisplatin; Dictyostelium; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance; Etoposide; Fluorouracil; Microscopy, Fluorescence; Models, Genetic; Molecular Sequence Data; Mutation; Phosphotransferases (Alcohol Group Acceptor); Recombination, Genetic; Sensitivity and Specificity; Sequence Homology, Amino Acid; Sphingosine; Time Factors | 2005 |
Confocal restricted-height imaging of suspension cells (CRISC) in a PDMS microdevice during apoptosis.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Apoptosis; Dimethylpolysiloxanes; Equipment Design; Etoposide; Humans; Microfluidics; Microscopy, Confocal; Particle Size; Sensitivity and Specificity; Surface Properties; Tumor Necrosis Factor-alpha; U937 Cells | 2005 |
1H MRS-visible lipids accumulate during apoptosis of lymphoma cells in vitro and in vivo.
Topics: Animals; Apoptosis; Biomarkers, Tumor; Cell Count; Cell Line, Tumor; Etoposide; Female; Lipid Metabolism; Lymphoma; Magnetic Resonance Spectroscopy; Mice; Mice, Inbred C57BL; Protons; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic | 2005 |
Correlation between decreased sensitivity of the Daudi lymphoma cells to VP-16-induced apoptosis and deficiency in DNAS1L3 expression.
Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; Apoptosis Regulatory Proteins; ATP Binding Cassette Transporter, Subfamily B, Member 1; bcl-2-Associated X Protein; bcl-Associated Death Protein; Calcium; Caspase 3; Caspases; Cell Line, Tumor; Deoxyribonucleases; DNA; DNA Damage; DNA Fragmentation; DNA Topoisomerases, Type II; Drug Resistance, Neoplasm; Endodeoxyribonucleases; Enzyme Activation; Etoposide; Gene Deletion; Gene Expression Regulation, Neoplastic; Humans; Immunoblotting; In Situ Nick-End Labeling; Intracellular Signaling Peptides and Proteins; Lymphoma; Magnesium; Membrane Potentials; Nucleosomes; Poly-ADP-Ribose Binding Proteins; Proteins; Proto-Oncogene Proteins c-bcl-2; Reverse Transcriptase Polymerase Chain Reaction; Sensitivity and Specificity; Transfection; U937 Cells | 2006 |
Herceptin sensitizes ErbB2-overexpressing cells to apoptosis by reducing antiapoptotic Mcl-1 expression.
Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Apoptosis; Cell Line, Tumor; Etoposide; Gene Expression Regulation, Neoplastic; Genes, erbB-2; Humans; Mice; Myeloid Cell Leukemia Sequence 1 Protein; Neoplasm Proteins; Oligoribonucleotides, Antisense; Paclitaxel; Proto-Oncogene Proteins c-bcl-2; Sensitivity and Specificity; Trastuzumab; Tumor Cells, Cultured | 2006 |
Contralateral testicular cancer in spite of TIN-negative double biopsies and interval cisplatin chemotherapy.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bleomycin; Cisplatin; Etoposide; False Negative Reactions; Humans; Magnetic Resonance Imaging; Male; Neoplasms, Germ Cell and Embryonal; Neoplasms, Second Primary; Predictive Value of Tests; Sensitivity and Specificity; Testicular Neoplasms; Testis; Time Factors | 2006 |
Cardiac effects within 3 months of BEAC high-dose therapy in non-Hodgkin's lymphoma patients undergoing autologous stem cell transplantation.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Atrial Natriuretic Factor; Biomarkers; Carmustine; Cyclophosphamide; Cytarabine; Etoposide; Female; Gated Blood-Pool Imaging; Heart; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Peripheral Blood Stem Cell Transplantation; Postoperative Complications; Postoperative Period; Prospective Studies; Protein Precursors; Sensitivity and Specificity; Stroke Volume; Systole; Transplantation, Autologous; Ventricular Dysfunction, Left | 2006 |
Successful chemotherapy and 90Y-DOTATOC in a patient with mediastinal highly aggressive neuroendocrine carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Neuroendocrine; Disease Progression; Etoposide; Female; Humans; Mediastinal Neoplasms; Middle Aged; Neoplasms, Unknown Primary; Octreotide; Remission Induction; Risk Factors; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome | 2006 |
Data acquisition for the histoculture drug response assay in lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Cisplatin; Deoxycytidine; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Etoposide; Female; Fluorouracil; Gemcitabine; Humans; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Probability; Retrospective Studies; Sensitivity and Specificity; Tumor Cells, Cultured | 2007 |
Collagen gel matrix assay as an in vitro chemosensitivity test for malignant astrocytic tumors.
Topics: Adult; Aged; Antineoplastic Agents; Astrocytoma; Carboplatin; Central Nervous System Neoplasms; Cisplatin; Collagen; Disease Progression; Disease-Free Survival; Drug Screening Assays, Antitumor; Etoposide; Female; Fibrin Foam; Follow-Up Studies; Glioblastoma; Humans; Japan; Karnofsky Performance Status; Male; Middle Aged; Nimustine; Sensitivity and Specificity; Survival Analysis; Tissue Adhesives; Treatment Outcome; Tumor Burden; Tumor Cells, Cultured | 2007 |
Serum levels of interleukin-10 in patients with diffuse large cell lymphoma: lack of correlation with prognosis.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Cisplatin; Cyclophosphamide; Cytarabine; Doxorubicin; Enzyme-Linked Immunosorbent Assay; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Interleukin-10; Life Tables; Lymphoma, Large B-Cell, Diffuse; Male; Mesna; Methotrexate; Methylprednisolone Hemisuccinate; Middle Aged; Mitoxantrone; Neoplasm Proteins; Prognosis; Risk Factors; Sensitivity and Specificity; Severity of Illness Index; Survival Analysis; Treatment Outcome; Vincristine | 1995 |
O-phospho-L-tyrosine inhibits cellular growth by activating protein tyrosine phosphatases.
Topics: Breast Neoplasms; Carcinoma, Renal Cell; Cell Death; Cell Division; Doxorubicin; Enzyme Activation; Epidermal Growth Factor; ErbB Receptors; Etoposide; Humans; Kidney Neoplasms; Neoplasm Proteins; Phosphorylation; Phosphotyrosine; Protein Tyrosine Phosphatases; S Phase; Sensitivity and Specificity; Tumor Cells, Cultured; Tyrosine | 1993 |
SEQPWR and SEQOPR: computer programs for design of maximum information trials based on group sequential logrank tests.
Topics: Algorithms; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Small Cell; Cisplatin; Clinical Trials as Topic; Clinical Trials, Phase III as Topic; Data Interpretation, Statistical; Etoposide; Feasibility Studies; Follow-Up Studies; Humans; Linear Models; Lung Neoplasms; Programming Languages; Research Design; Sensitivity and Specificity; Software; Survival Rate; Topotecan | 1995 |
Clinical significance of DNA measurements in small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bronchi; Carcinoma, Small Cell; Cisplatin; DNA, Neoplasm; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Ploidies; Probability; Prognosis; Remission Induction; Sensitivity and Specificity | 1993 |
A temperature sensitive topoisomerase II allele confers temperature dependent drug resistance on amsacrine and etoposide: a genetic system for determining the targets of topoisomerase II inhibitors.
Topics: Alleles; Amsacrine; Camptothecin; Cell Division; DNA Damage; DNA Repair; DNA Topoisomerases, Type II; Drug Resistance; Etoposide; Models, Biological; Saccharomyces cerevisiae; Sensitivity and Specificity; Temperature; Topoisomerase II Inhibitors | 1993 |
Transfection of wild-type but not mutant p53 induces early monocytic differentiation in HL60 cells and increases their sensitivity to stress.
Topics: Antigens, Surface; Base Sequence; Blood Proteins; Cell Differentiation; Cell Division; Culture Media; Dimethyl Sulfoxide; Etoposide; HL-60 Cells; Humans; Molecular Sequence Data; Monocytes; Sensitivity and Specificity; Tetradecanoylphorbol Acetate; Transfection; Tumor Suppressor Protein p53 | 1995 |
Clinical significance of bone marrow metastases as detected using the polymerase chain reaction in patients with breast cancer undergoing high-dose chemotherapy and autologous bone marrow transplantation.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Neoplasms; Bone Marrow Transplantation; Breast Neoplasms; Carboplatin; Combined Modality Therapy; Disease-Free Survival; Etoposide; Female; Humans; Ifosfamide; Immunohistochemistry; Keratins; Middle Aged; Polymerase Chain Reaction; Prognosis; Recurrence; Retrospective Studies; Sensitivity and Specificity | 1996 |
Automated monitoring of apoptosis in suspension cell cultures.
Topics: Animals; Apoptosis; Automation; Cell Line; Cells, Cultured; Cisplatin; Cytological Techniques; DNA Damage; Ethanol; Etoposide; Female; HL-60 Cells; Humans; Hydrogen Peroxide; Kinetics; Mice; Mice, Inbred C57BL; Necrosis; Reproducibility of Results; Sensitivity and Specificity; Thymus Gland | 1996 |
Monoclonal antibody to single-stranded DNA is a specific and sensitive cellular marker of apoptosis.
Topics: Animals; Antibodies, Monoclonal; Apoptosis; Biomarkers; Cell Line; Cisplatin; DNA, Single-Stranded; Etoposide; Fluorescent Antibody Technique, Indirect; HL-60 Cells; Humans; Immunohistochemistry; Leukemia; Mice; Necrosis; Sensitivity and Specificity; Tumor Cells, Cultured | 1996 |
Method for quantifying expression of functionally active topoisomerase II in patients with leukaemia.
Topics: Adolescent; Adult; Aged; Animals; Biochemistry; Blastomeres; Crithidia fasciculata; DNA Topoisomerases, Type II; DNA, Kinetoplast; Doxorubicin; Ellipticines; Ethylmaleimide; Etoposide; Female; Humans; Male; Middle Aged; Novobiocin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Sensitivity and Specificity; Topoisomerase II Inhibitors | 1996 |
Determination of unbound etoposide concentration in ultrafiltered plasma by high-performance liquid chromatography with fluorimetric detection.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Calibration; Carcinoma, Hepatocellular; Chromatography, High Pressure Liquid; Etoposide; Fluorometry; Hemofiltration; Humans; Linear Models; Liver Neoplasms; Middle Aged; Reproducibility of Results; Sensitivity and Specificity; Spectrophotometry, Ultraviolet | 1996 |
N-myc amplification and its relationship to experimental therapy.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Drug Resistance, Neoplasm; Etoposide; Gene Amplification; Genes, myc; Genetic Therapy; Humans; Neuroblastoma; Sensitivity and Specificity; Tumor Cells, Cultured | 1997 |
Determination of a new podophyllotoxin derivative, TOP-53, and its metabolite in rat plasma and urine by high-performance liquid chromatography with electrochemical detection.
Topics: Animals; Antineoplastic Agents, Phytogenic; Chromatography, High Pressure Liquid; Drug Stability; Electrochemistry; Etoposide; Glucuronates; Rats; Sensitivity and Specificity | 1997 |
CEA, CA 19-9, and CA-50 in monitoring gastric carcinoma.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antigens, Tumor-Associated, Carbohydrate; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; CA-19-9 Antigen; Carcinoembryonic Antigen; Carcinoma; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Epirubicin; Etoposide; Female; Humans; Incidence; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Palliative Care; Prognosis; Prospective Studies; Sensitivity and Specificity; Stomach Neoplasms; Treatment Outcome | 1997 |
Determination of the cytotoxic catechol metabolite of etoposide (3'O-demethyletoposide) in human plasma by high-performance liquid chromatography.
Topics: Antineoplastic Agents, Phytogenic; Chromatography, High Pressure Liquid; Circadian Rhythm; Dealkylation; Drug Stability; Electrochemistry; Etoposide; Humans; Linear Models; Osmolar Concentration; Reproducibility of Results; Sensitivity and Specificity; Time Factors | 1997 |
Apoptosis induced by X-rays and chemical agents in murine fibroblastic cell lines with a defect in repair of DNA double-strand breaks.
Topics: 3T3 Cells; Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Apoptosis; Bleomycin; Cisplatin; DNA; DNA Damage; DNA Repair; DNA-Activated Protein Kinase; DNA-Binding Proteins; Etoposide; Fibroblasts; Humans; Mice; Mice, Inbred BALB C; Mice, SCID; Nuclear Proteins; Protein Serine-Threonine Kinases; Radiation-Sensitizing Agents; Sensitivity and Specificity; Ultraviolet Rays; X-Rays | 1998 |
Nuclear foci of mammalian recombination proteins are located at single-stranded DNA regions formed after DNA damage.
Topics: Animals; Cell Cycle; Cell Line; Cell Nucleus; Chromatin; Cycloheximide; Dactinomycin; DNA Damage; DNA, Single-Stranded; Etoposide; Fibroblasts; Gamma Rays; Humans; Kinetics; Mammals; Meiosis; Mitomycin; Nuclear Proteins; Rats; Recombinant Proteins; Sensitivity and Specificity; Xeroderma Pigmentosum | 1999 |
Activity of SCH 66336, a tricyclic farnesyltransferase inhibitor, against human tumor colony-forming units.
Topics: Alkyl and Aryl Transferases; Cell Survival; Cisplatin; Clone Cells; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Farnesyltranstransferase; Humans; Neoplasms; Neoplastic Stem Cells; Paclitaxel; Piperidines; Pyridines; Sensitivity and Specificity; Tumor Cells, Cultured; Tumor Stem Cell Assay | 1999 |
A new PCR MIMIC strategy to quantify low mdr1 mRNA levels in drug resistant cell lines and AML blast samples.
Topics: Acute Disease; Adolescent; Adult; Aged; Antigens, CD34; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Binding, Competitive; Chromosome Banding; Cytarabine; Daunorubicin; DNA, Complementary; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Etoposide; Gene Expression Regulation, Leukemic; Genes, MDR; Humans; K562 Cells; Leukemia, Myeloid; Middle Aged; Mitoxantrone; Neoplasm Proteins; Neoplastic Stem Cells; Oligonucleotide Probes; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Neoplasm; Sensitivity and Specificity; Tumor Cells, Cultured | 1999 |
Simultaneous quantitation of etoposide and its catechol metabolite in human plasma using high-performance liquid chromatography with electrochemical detection.
Topics: Antineoplastic Agents, Phytogenic; Catechols; Chromatography, High Pressure Liquid; Electrochemistry; Etoposide; Humans; Reference Standards; Reproducibility of Results; Sensitivity and Specificity | 1999 |
Primary small cell carcinoma of the esophagus with achalasia in a patient in whom pro-gastrin-releasing peptide and neuron-specific enolase levels reflected the clinical course during chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoma, Small Cell; Cisplatin; Cyclophosphamide; Esophageal Achalasia; Esophageal Neoplasms; Esophagoscopy; Etoposide; Humans; Male; Middle Aged; Peptide Fragments; Peptides; Phosphopyruvate Hydratase; Prognosis; Recombinant Proteins; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome | 1999 |
RT-PCR evaluation of peripheral blood, bone marrow and peripheral blood stem cells in children and adolescents undergoing VACIME chemotherapy for Ewing's sarcoma and alveolar rhabdomyosarcoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Bone Marrow Purging; Bone Neoplasms; Child; Chromosomes, Human, Pair 11; Chromosomes, Human, Pair 13; Chromosomes, Human, Pair 2; Chromosomes, Human, Pair 22; Combined Modality Therapy; Cyclophosphamide; DNA-Binding Proteins; Doxorubicin; Etoposide; Female; Forkhead Box Protein O1; Forkhead Transcription Factors; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Ifosfamide; Male; Mesna; Neoplasm Proteins; Neoplastic Cells, Circulating; Oncogene Proteins, Fusion; Paired Box Transcription Factors; PAX3 Transcription Factor; Proto-Oncogene Protein c-fli-1; Reverse Transcriptase Polymerase Chain Reaction; Rhabdomyosarcoma, Alveolar; RNA-Binding Protein EWS; Sarcoma, Ewing; Sensitivity and Specificity; Soft Tissue Neoplasms; Transcription Factors; Translocation, Genetic; Vincristine | 1999 |
Protection of acute myeloblastic leukemia cells against apoptotic cell death by high glutathione and gamma-glutamylcysteine synthetase levels during etoposide-induced oxidative stress.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Blotting, Western; Drug Resistance, Neoplasm; Etoposide; Flow Cytometry; Glutamate-Cysteine Ligase; Humans; Leukemia, Myeloid, Acute; Oxidative Stress; Sensitivity and Specificity; Tumor Cells, Cultured | 1999 |
Stochastic modeling of apoptosis tolerance distributions measured by multivariate flow analysis of human leukemia cells.
Topics: Apoptosis; Etoposide; Flow Cytometry; Humans; Intracellular Membranes; Leukemia; Light; Likelihood Functions; Linear Models; Membrane Lipids; Membrane Potentials; Mitochondria; Multivariate Analysis; Phosphatidylserines; Scattering, Radiation; Sensitivity and Specificity; Stochastic Processes; Tumor Cells, Cultured | 2000 |
Highly sensitive liquid chromatography-electrospray mass spectrometry (LC-MS) method for the determination of etoposide levels in human serum and plasma.
Topics: Antineoplastic Agents, Phytogenic; Calibration; Chromatography, Liquid; Etoposide; Humans; Mass Spectrometry; Neoplasms; Quality Control; Sensitivity and Specificity | 2000 |
Thymidine incorporation is highly predictive of colony formation and can be used for high-throughput screening.
Topics: Animals; Antineoplastic Agents; Cell Division; Cell Survival; Chickens; CHO Cells; Colonic Neoplasms; Colony-Forming Units Assay; Cricetinae; Drug Screening Assays, Antitumor; Etoposide; Humans; Hydroxyurea; Kidney Neoplasms; Lung Neoplasms; Paclitaxel; Sensitivity and Specificity; Thymidine; Tritium; Tumor Cells, Cultured | 2001 |
Simultaneous quantification of etoposide and etoposide phosphate in human plasma by capillary electrophoresis using laser-induced native fluorescence detection.
Topics: Antineoplastic Agents; Electrophoresis, Capillary; Etoposide; Humans; Lasers; Male; Organophosphorus Compounds; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Fluorescence | 2001 |
Determination of etoposide in human plasma and leukemic cells by high-performance liquid chromatography with electrochemical detection.
Topics: Antineoplastic Agents, Phytogenic; Chromatography, High Pressure Liquid; Electrochemistry; Etoposide; Humans; Leukemia, Myeloid, Acute; Quality Control; Reproducibility of Results; Sensitivity and Specificity | 2001 |
Simultaneous determination of etoposide and its catechol metabolite in the plasma of pediatric patients by liquid chromatography/tandem mass spectrometry.
Topics: Antineoplastic Agents, Phytogenic; Ascorbic Acid; Calibration; Catechols; Child; Chromatography, High Pressure Liquid; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Drug Stability; Etoposide; Genotype; Humans; Linear Models; Mass Spectrometry; Mixed Function Oxygenases; Oxidation-Reduction; Quinine; Reproducibility of Results; Sensitivity and Specificity | 2001 |
Sensitivity of soft tissue sarcoma cell lines to chemotherapeutic agents: identification of ecteinascidin-743 as a potent cytotoxic agent.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blotting, Western; Cell Cycle; Cell Survival; Dioxoles; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Humans; Inhibitory Concentration 50; Isoquinolines; Methotrexate; Proto-Oncogene Proteins c-bcl-2; Retinoblastoma Protein; Sarcoma; Sensitivity and Specificity; Tetrahydroisoquinolines; Trabectedin; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 2001 |
Sensitive markers used to identify compounds that trigger apoptosis in cultured hepatocytes.
Topics: Animals; Apoptosis; bcl-X Protein; Biomarkers; Camptothecin; Caspase 3; Caspases; Cells, Cultured; Curcumin; Cytochrome c Group; DNA; DNA Fragmentation; Down-Regulation; Etoposide; Flow Cytometry; Galactosamine; Hepatocytes; Male; Mitochondria; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Sprague-Dawley; Sensitivity and Specificity; tert-Butylhydroperoxide; Xenobiotics | 2002 |
Determination of etoposide phosphate intermediates by gradient liquid chromatography using postcolumn derivatization with cuprammonium hydroxide.
Topics: Antineoplastic Agents; Chromatography, Liquid; Etoposide; Hydroxides; Organophosphorus Compounds; Prodrugs; Reproducibility of Results; Sensitivity and Specificity; Spectrophotometry, Ultraviolet | 2002 |
Urate-oxidase in the prevention and treatment of metabolic complications in patients with B-cell lymphoma and leukemia, treated in the Société Française d'Oncologie Pédiatrique LMB89 protocol.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; France; Humans; Hydrocortisone; Leucovorin; Lymphoma, B-Cell; Male; Methotrexate; Neoplasm Staging; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Retrospective Studies; Risk Assessment; Sensitivity and Specificity; Survival Rate; Treatment Outcome; Tumor Lysis Syndrome; Urate Oxidase; Vincristine | 2002 |